In VitroActivities of Retapamulin and 16 Other Antimicrobial Agents against Recently Obtained Streptococcus pyogenes Isolates

Emergence of Resistance among USA300 Methicillin-Resistant Staphylococcus aureus Isolates Causing Invasive Disease in the United States

(2010) L. K. McDougal et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antimicrobial Resistance among Respiratory Pathogens in Spain: Latest Data and Changes over 11 Years (1996-1997 to 2006-2007)

(2010) E. Perez-Trallero et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008)

(2010) M. Castanheira et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Mupirocin-resistant MRSA transmission associated with community hospitals and nursing homes

(2010) M.J. Brian   JOURNAL OF HOSPITAL INFECTION

Prevalence and Clonal Characterization of Streptococcus pyogenes Clinical Isolates with Reduced Fluoroquinolone Susceptibility in Spain

(2009) M. Montes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Resistance to bacitracin inStreptococcus pyogenesfrom oropharyngeal colonization and noninvasive infections in Portugal was caused by two clones of distinct virulence genotypes

(2009) Renato Pires et al.   FEMS MICROBIOLOGY LETTERS

Epidemiological analysis of Streptococcus pyogenes infections in Hong Kong

(2009) Janice C.K. Chan et al.   PATHOLOGY

Proposed MIC and Disk Diffusion Microbiological Cutoffs and Spectrum of Activity of Retapamulin, a Novel Topical Antimicrobial Agent

(2008) M. M. Traczewski et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY